Sanaka India Advisors

Founder Shankar Narayanan, former Managing Director and Co-Head of Carlyle Asia Growth Capital, leads the investment strategy. He is supported by Partner Neeraj Bhatia and Director Rumen Barjatya, both of whom bring independent deal leadership experience. Narayanan's investment career dates to 1993, and he has held CEO roles at portfolio companies during his tenure at Hathway Investments and Carlyle.

Sanaka India Advisors is a SEBI-registered investment adviser that provides non-binding recommendations on alternative investments exclusively to the Sanaka Group. The advisory entity does not manage external capital and operates under a compliance framework that includes a designated principal officer and a published registration number — a governance structure uncommon among single-family investment platforms in India.

Sanaka's disclosed portfolio covers growth-stage and late-stage private companies, as well as venture positions in biopharma and SaaS. The firm has invested in healthcare analytics (CorroHealth), engineering services (Quest Global), retirement-plan software (Congruent Solutions), distribution management SaaS (Botree Software), biotherapeutics (Nueva Bio), and financial services (Edelweiss). It pursues both direct positions and co-investments across India, the US, and Singapore.

The firm's public disclosures describe only direct investments into operating companies. No information about commitments to third-party funds, SPVs, or fund-of-funds vehicles is available; its model appears to center on balance-sheet equity deployment and selective co-investments.

Sanaka's portfolio spans India, the United States, and Singapore. Indian holdings include Chennai-based Congruent Solutions and Botree Software, while US investments feature Texas-based CorroHealth and California-based Nueva Bio. Quest Global, though operationally present in 17 countries, is headquartered in Singapore.

Sanaka has not publicly articulated a co-investment program. Its website and portfolio disclosures describe only proprietary capital deployment. No statements or press releases indicate participation in club deals or syndicated rounds led by external GPs.

Sanaka's regulatory filings and public communications frame it as an advisor solely to the Sanaka Group. It is not currently marketing a fund vehicle to outside investors. Bina Trivedi's experience raising capital from family offices and UHNWIs was in prior roles, not at Sanaka.